Toward quantitating the burden of glomerulonephritis in the United States

Kidney Int. 2016 Oct;90(4):732-4. doi: 10.1016/j.kint.2016.06.004.

Abstract

Previous data attempting to quantitate the national burden of glomerulonephritis (GN) have been derived from regional biopsy series or end-stage renal disease registries. Wetmore et al. is the first to address this question based on claims data extracted from 2 large U.S. health care systems. Although there are limitations, it provides broad-based epidemiological data that demonstrate a significant underestimate of the extent of GN disease and provide an important first step in its quantitation.

Publication types

  • Comment

MeSH terms

  • Biopsy
  • Glomerulonephritis*
  • Humans
  • Incidence
  • Kidney Failure, Chronic*
  • Prevalence
  • Retrospective Studies
  • United States